Low - dose CT of the chest as a screening method for early detection of pulmonary cancer

Dose limitation is one of the vital principles in radiation protection regulation. The use of that Low-dose chest CT can be a screening method of choice for early detection of pulmonary cancer

64-слојна компјутеризирана томографија на крвни садови на глава и врат

64 КТ Ангиографија - Современа неинвазивна метода за преглед на каротидните и мозочните артерии; Вродени аномалии и анатомски варијации; Детекција на трауми-руптури; Приказ на патолошка васкуларизација на тумори; Детекција на стенози; Предоперативно планирање; Постоперативни контроли; Планирање на стентирање и контроли; Мали аневризми (фокални проширувања) на интракранијални крвни садови

Pitfalls in coronary CT angiography with 64 VCT Light Speed – GE - our initial experience

To share our initial experience and pitfalls during performance of the coronary CT angiography (coronary CTA)with 64 VCT Light Speed as well as our suggestions for all beginners how to avoid them

ECG-gated 64-MDCT angiography –Diagnosis of acute aortic dissection

The purpose of this study is to show the value of ECG gated 64-MDCT as a non-invasive and reliable method for the evaluation of acute aortic dissection with significantly reduced motion artefacts of the thoracic aorta and the supraaortic vessels, at the same time allowing non-invasive assessment of the coronary arteries as part of the aortic root evaluation

Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings

Objectives: Elderly patients with hematologic malignancies face the highest risk of severe COVID-19 outcomes. The infection's impact on different age groups remains unstudied in detail. Methods: We analyzed elderly patients (age groups: 65-70, 71-75, 76-80, and >80 years old) with hematologic malignancies included in the EPICOVIDEHA registry between January 2020 and July 2022. Univariable and multivariable Cox regression models were conducted to identify factors influencing death in COVID-19 patients with hematological malignancy. Results: The study included data from 3,603 elderly patients (aged 65 or older) with hematological malignancy, with a majority being male (58.1%) and a significant proportion having comorbidities. The patients were divided into four age groups, and the analysis assessed COVID-19 outcomes, vaccination status, and other variables in relation to age and pandemic waves. The 90-day survival rate for patients with COVID-19 was 71.2%, with significant differences between groups. The pandemic waves had varying impacts, with the first wave affecting patients over 80 years old, the second being more severe in 65-70, and the third being the least severe in all age groups. Factors contributing to 90-day mortality included age, comorbidities, lymphopenia, active malignancy, acute leukemia, less than three vaccine doses, severe COVID-19, and using only corticosteroids as treatment. Conclusion: These data underscore the heterogeneity of elderly hematological patients, highlight the different impacts of COVID-19 waves and the pivotal importance of vaccination, and may help in planning future healthcare efforts